CLINICAL_TRIALS
trial_result
· 2015-04-01
Clinical Trial Update: Liraglutide as add-on to Insulin in Type 1 Diabetes [Phase 3]
Summary
A Phase 3 trial evaluating liraglutide as an add-on to insulin in Type 1 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hvidovre University Hospital | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED